Bottom-Up Synthesis and Purification of Extracellular Vesicle Mimetics

Area of Science:

• Biotechnology
• Nanotechnology
• Cell Biology

Background:

• Extracellular vesicles (EVs) are natural nanoparticles with therapeutic potential for drug delivery.
• Limitations of natural EVs include complex production, variability, and inefficient cargo loading.
• EV mimetics offer a promising alternative to overcome these challenges.

Purpose of the Study:

• To develop a novel method for producing EV mimetics using cell-free protein synthesis.
• To demonstrate the functional incorporation of EV-associated membrane proteins into liposomes.
• To establish a controllable and scalable platform for EV-inspired drug delivery systems.

Main Methods:

• Cell-free protein synthesis to produce full-length membrane proteins (CD47, CD39, N-Cadherin).
• Incorporation of synthesized proteins into liposomal bilayers to create EV mimetics.
• Characterization using proteinase K protection assays and immuno-labeling electron microscopy.
• Functional assessment via cell uptake studies.

Main Results:

• Successful production and purification of EV mimetics containing CD47, CD39, and N-Cadherin.
• Optimized reaction conditions enhanced CD47 EV mimetic yield.
• Preserved membrane protein topology (CD47, CD39) and functionality (N-Cadherin) demonstrated.
• EV mimetics showed versatility with various liposomal formulations and co-incorporation of multiple proteins.

Conclusions:

• Cell-free synthesis provides a modular and controllable strategy for creating functional EV mimetics.
• These EV mimetics address key limitations of natural EVs for drug delivery applications.
• The developed platform offers a scalable and versatile approach for advancing EV-inspired therapeutics.